ArticleJournal of radiation research2025
Comparative evaluation of flattening filter (FF) and flattening filter-free (FFF) radiotherapy beams: melatonin's radioprotective role on thyroid and laryngeal tissues in rat model.
Article in Journal of radiation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to evaluate the radioprotective effects of melatonin on healthy thyroid and laryngeal tissues exposed to head and neck radiotherapy using flattening filter (FF) and flattening filter-free (FFF) radiotherapy beams. Forty-eight female Wistar albino rats were randomly assigned to five groups (n = 8): control, only melatonin, FF, FF + melatonin, FFF and FFF + melatonin. A single 16 Gy dose of radiation was delivered to the head and neck region using a linear accelerator. Melatonin (50 mg/kg) was administered intraperitoneally 15 minutes prior to irradiation. Biochemical parameters including malondialdehyde (MDA), myeloperoxidase (MPO), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) were measured from serum samples. Histopathological evaluations of thyroid (inflammation, epithelial hyperplasia, follicular hyperplasia, C-cell hyperplasia, cellular degeneration, follicular cell hypertrophy and cellular necrosis) and laryngeal (general morphological deterioration, inflammation, oedema, epithelial destruction, karyorrhexis and karyolysis) tissues were performed using a semi-quantitative scoring system. FF and FFF beam exposure significantly increased MDA and MPO levels while reducing antioxidant enzyme activities (SOD, CAT, GPx) compared to the control group (P < 0.05). Histologically, both radiation types induced marked inflammation, cellular damage and morphological degeneration in thyroid and laryngeal tissues. Melatonin administration significantly reversed these effects, improving antioxidant enzyme levels and mitigating tissue damage (P < 0.05). No statistically significant difference was observed between FF and FFF groups in either biochemical or histological outcomes. FF and FFF beams produced comparable levels of oxidative and structural damage in healthy tissues. Melatonin demonstrated significant radioprotective effects through both biochemical and histopathological pathways, suggesting its potential role in mitigating radiotherapy-induced toxicity in non-target tissues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.